Lausanne-based cancer research and tissue diagnostics company Lunaphore Technologies has closed its Series C funding for the second time at SFr25m (US$25.7m). The SFr2m Series C2 financing was provided by…
Lausanne-based cancer research and tissue diagnostics company Lunaphore Technologies has closed its Series C funding for the second time at SFr25m (US$25.7m). The SFr2m Series C2 financing was provided by…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


